After winning approval in the United States back in September, Sanofi Genzyme’s multiple sclerosis drug, aubagio, has won approval for use in Australia. The Australian Therapeutic Goods ...

In its 28th year, the annual MPW list recognizes 100 women leading major global companies. This year, 21 listees are at the ...

Seven-Year Ofatumumab Data Ofatumumab was approved for MS based on the phase III ASCLEPIOS trials that compared the drug with teriflunomide ... Sanofi Genzyme, EMD Serono, Novartis, TG ...

By Mariam Sunny and Siddhi Mahatole (Reuters) -French drugmaker Sanofi said the U.S. Food and Drug Administration has ...

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. GSK had expected to secure an FDA ...

She now covers breaking and trending news for CBS News' HealthWatch. The Food and Drug Administration is warning the public about the harmful effects of products containing tianeptine, also ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT systems and potentially accelerating its reviews of medical products.

The FDA has suspended a quality control program for testing milk and dairy products, according to Reuters. The program is paused due to reduced lab capacity, and it’s unclear when it will resume.

The FDA approved three natural food dyes this week amid its transition away from petroleum-based dyes in the food supply. The colors "will expand the palette of available colors from natural ...

The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research ...

The Food and Drug Administration has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. The meetings appear to be part of a broader ...